稳定易损斑块：寻找神奇疗法 - Suppr

Suppr

超能文献

Stabilizing the vulnerable plaque: the search for the magic bullet.

作者信息

Pasterkamp G, Daemen M

出版信息

Curr Pharm Des. 2007;13(10):979-82. doi: 10.2174/138161207780487539.

DOI:10.2174/138161207780487539

PMID:17430161

Abstract

摘要

相似文献

Stabilizing the vulnerable plaque: the search for the magic bullet.

Curr Pharm Des. 2007;13(10):979-82. doi: 10.2174/138161207780487539.

Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions.

Atherosclerosis. 2018 Sep;276:98-108. doi: 10.1016/j.atherosclerosis.2018.07.014. Epub 2018 Jul 25.

Targeting inflammation in cardiovascular diseases. still a neglected field?

Cardiovasc Ther. 2012 Aug;30(4):e189-97. doi: 10.1111/j.1755-5922.2011.00274.x. Epub 2011 Apr 1.

Editorial: Treatment of atherosclerosis as an inflammatory disease.

Curr Pharm Des. 2012;18(28):4265.

Anti-inflammatory therapeutics for the treatment of atherosclerosis.

Nat Rev Drug Discov. 2011 May;10(5):365-76. doi: 10.1038/nrd3444.

Chemokines and atherosclerotic plaque progression: towards therapeutic targeting?

Curr Pharm Des. 2007;13(10):1039-52. doi: 10.2174/138161207780487584.

Autoimmunity and autoinflammation: cardiovascular drug targets and design.

Curr Pharm Des. 2014;20(4):483-5. doi: 10.2174/138161282004140213121733.

Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis.

Expert Opin Emerg Drugs. 2017 Mar;22(1):1-26. doi: 10.1080/14728214.2017.1269743. Epub 2016 Dec 22.

Atherosclerosis revisited from a clinical perspective: still an inflammatory disease?

Thromb Haemost. 2017 Jan 26;117(2):231-237. doi: 10.1160/TH16-10-0770. Epub 2016 Dec 15.

Research Progress of Mechanisms and Drug Therapy For Atherosclerosis on Toll-Like Receptor Pathway.

J Cardiovasc Pharmacol. 2019 Nov;74(5):379-388. doi: 10.1097/FJC.0000000000000738.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Stabilizing the vulnerable plaque: the search for the magic bullet.

Curr Pharm Des. 2007;13(10):979-82. doi: 10.2174/138161207780487539.

Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions.

Atherosclerosis. 2018 Sep;276:98-108. doi: 10.1016/j.atherosclerosis.2018.07.014. Epub 2018 Jul 25.

Targeting inflammation in cardiovascular diseases. still a neglected field?

Cardiovasc Ther. 2012 Aug;30(4):e189-97. doi: 10.1111/j.1755-5922.2011.00274.x. Epub 2011 Apr 1.

Editorial: Treatment of atherosclerosis as an inflammatory disease.

Curr Pharm Des. 2012;18(28):4265.

Anti-inflammatory therapeutics for the treatment of atherosclerosis.

Nat Rev Drug Discov. 2011 May;10(5):365-76. doi: 10.1038/nrd3444.

Chemokines and atherosclerotic plaque progression: towards therapeutic targeting?

Curr Pharm Des. 2007;13(10):1039-52. doi: 10.2174/138161207780487584.

Autoimmunity and autoinflammation: cardiovascular drug targets and design.

Curr Pharm Des. 2014;20(4):483-5. doi: 10.2174/138161282004140213121733.

Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis.

Expert Opin Emerg Drugs. 2017 Mar;22(1):1-26. doi: 10.1080/14728214.2017.1269743. Epub 2016 Dec 22.

Atherosclerosis revisited from a clinical perspective: still an inflammatory disease?

Thromb Haemost. 2017 Jan 26;117(2):231-237. doi: 10.1160/TH16-10-0770. Epub 2016 Dec 15.

Research Progress of Mechanisms and Drug Therapy For Atherosclerosis on Toll-Like Receptor Pathway.

J Cardiovasc Pharmacol. 2019 Nov;74(5):379-388. doi: 10.1097/FJC.0000000000000738.